Taken together with the fact that ANKLE1-mediated risk of breast cancer is primarily through its effect on the TNBC subtype, of which 80% are mutant for TP5332, we hypothesized that TP53 mutations allow cells that express ANKLE1 ectopically to evade apoptosis. Here, TP53 is linked to breast carcinoma.